-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NHP Models for HIV Therapeutics and Microbiocides.
Date: November 16, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Holiday Inn Capitol, 550 C Street, SW., Saturn/Venus Room, Washington, DC 20024.
Contact Person: Lucy A. Ward, DVM, PhD., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID/DHHS, 6700B Rockledge Drive, Bethesda, MD 20892-7616, 301-496-2550, lward@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Clinical Pharmacology Quality Assurance and Quality Control.
Date: November 16, 2007.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, 3147, Bethesda, MD 20817. (Telephone Conference Call)
Contact Person: Mary J. Homer, PhD., Scientific Review Administrator, Scientific Review Program, National Institute of Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge Drive MSC 7616 Room 3147, Bethesda, MD 20892, 301-496-7042, mjhomer@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Start SignatureDated: October 19, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5289 Filed 10-24-07; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Effective Date:
- 11/16/2007
- Published:
- 10/25/2007
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 07-5289
- Dates:
- November 16, 2007.
- Pages:
- 60685-60685 (1 pages)
- PDF File:
- 07-5289.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute